Home » Topics » Disease categories and therapies » Dental

Dental
RSS

CollaGenex seeks FDA approval for new dosage form of Periostat

April 5, 2000

Xanthine-based cell adhesion inhibitors particularly useful for periodontitis

March 24, 2000

Periostat receives U.K. marketing approval for treatment of chronic adult periodontitis

March 1, 2000

Periodontix raises funding for further development of HistaWash

Jan. 21, 2000

Atridox periodontal therapy approved in E.U.

Jan. 6, 2000

PAX9 gene mutation results in missing teeth

Jan. 5, 2000

Cathepsin C may be an important mediator in the development of periodontitis

Dec. 16, 1999

Positive phase III trial results for OraPharma's periodontal disease treatment

Dec. 1, 1999

Taiho prepares novel agents for periodontitis

Nov. 11, 1999

Atrix reports postmarketing study results for Atridox periodontitis therapy

Sep. 30, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...